A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIa Study to Evaluate the Efficacy, Safety, and Tolerability of LW402 Tablets in Patients With Moderate to Severe Active Rheumatoid Arthritis
Latest Information Update: 14 Oct 2025
At a glance
- Drugs LW 402 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Longwood Biopharma
Most Recent Events
- 04 Feb 2025 New trial record